A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
Clinical trial NCT04173065 · COMPLETED
Trial details
- NCT number
- NCT04173065
- Sponsor
- Viking Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-15
- Primary completion
- 2023-05-15
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.